Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
Edesa Biotech, Inc. (SBOT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
10/11/2023 8-K Quarterly results
08/21/2023 SC 13D/A Pardeep Nijhawan Medicine Professional Corp reports a 20.9% stake in EDESA BIOTECH, INC.
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "Edesa Biotech Reports Fiscal Third Quarter 2023 Results"
05/24/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/24/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment No. 2 to Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results"
03/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/27/2023 8-K Quarterly results
03/27/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/27/2023 10-K/A Annual Report for the period ended September 30, 2022 [amend]
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
02/10/2023 10-Q Quarterly Report for the period ended December 31, 2022
02/10/2023 8-K Quarterly results
Docs: "Edesa Biotech Reports Fiscal 1st Quarter 2023 Results"
01/13/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/06/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/16/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
12/16/2022 10-K Annual Report for the period ended September 30, 2022
12/16/2022 8-K Quarterly results
Docs: "Edesa Biotech Reports Fiscal Year 2022 Results"
11/08/2022 SC 13D/A Pardeep Nijhawan Medicine Professional Corp reports a 22.1% stake in EDESA BIOTECH, INC.
11/03/2022 8-K Quarterly results
08/15/2022 EFFECT Form EFFECT - Notice of Effectiveness:
08/12/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/12/2022 8-K Quarterly results
Docs: "Edesa Biotech Reports Fiscal 3rd Quarter 2022 Results"
08/05/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
05/19/2022 8-K Quarterly results
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/13/2022 8-K Quarterly results
04/20/2022 EFFECT Form EFFECT - Notice of Effectiveness:
04/19/2022 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
04/11/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
04/05/2022 D Form D - Notice of Exempt Offering of Securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy